What does mathematical modeling tell us about harm reduction?

by Jonathan P. Caulkins

Purchase Print Copy

 FormatList Price
Add to Cart Paperback5 pages Free

This paper argues, primarily by example, that mathematical modeling can contribute to harm-reduction-oriented drug policymaking in three ways: by contributing to quantitative evaluations of effectiveness, by improving data and understanding of the underlying drug-related phenomena, and by encouraging precise thinking about the goals and objectives of harm reduction.

Originally published in: Drug and Alcohol Review, v. 15, 1996, pp. 231-235.

This report is part of the RAND Corporation reprint series. The Reprint was a product of the RAND Corporation from 1992 to 2011 that represented previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see External Publications.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.